Skip to main content
. Author manuscript; available in PMC: 2021 May 26.
Published in final edited form as: Liver Transpl. 2020 Jan;26(1):127–140. doi: 10.1002/lt.25681

Table 4:

Listing criteria and program components for LT for AH

Primary criteria Secondary considerations
Alcohol associated hepatitis assessment First presentation with decompensated AH No prior liver related hospitalization
Absence of severe medical comorbidities
  • Frailty, debility and multiorgan failure

  • No other contraindications to LT

Non-response or ineligible to medical therapy.
  • Contraindications: disease severity, multi organ failure, infection, renal failure and low likelihood for response

  • Consider non-responders using Lille score >=0.45 or worsening of liver function by d4 or d7

  • Monitor for signs of recovery after listing.

Alcohol use disorder assessment Establish acceptable risk of relapse as assessed by a multidisciplinary psychosocial team composed of a social worker and at least one addiction specialist.
  • Not intubated

  • Consider independent team of specialists in addiction, social workers, and mental health providers

  • Ideally first member of LT team to evaluate

  • Consider independent mechanisms for regional or local review

Direct assessment of patient possible by addiction specialist
  • i.e. not intubated or floridly encephalopathic.

A maximum of 1 prior failed attempt at rehabilitation.
Lack of other active substance use/dependency or active untreated psychiatric disorder
Acceptance of diagnosis/insight
Commitment of patient/family to sobriety and formalized agreement to adhere to lifelong total alcohol abstinence Establish contract and participation in addiction rehabilitation following transplant
Presence of close, supportive family members or caregivers
Committee Decision making Consensus of paramedical and medical staff Consider blinded voting in committee deliberations Consider absolute consensus
Program components Transparency in selection process LT reserved for patients with a favorable prognosis for long-term abstinence.
Independent psychosocial assessment
  • Mental health professional with addiction background/training

  • Mental health professional familiar with transplant process

Structured Post LT follow up mechanism in place
  • Documentation of AUD management plan pre and post-LT

  • Dedicated addiction specialist/mental health professional for longitudinal management

  • Commitment for regular monitoring for alcohol use Phosphatidylethanol (PEth), Urinary ethyl glucuronide

  • Structured monitoring program for post-transplant alcohol relapse and, in the event of alcohol relapse, provide resources to assist the patient in recovery

Team mental health
  • Consider formal addiction educatio for transplant staff